Valentino Martina

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. ncbi Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects
    Valentino Martina
    Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Italy
    Clin Endocrinol (Oxf) 64:260-4. 2006
  2. doi Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes
    Valentino Martina
    Department of Internal Medicine, University of Torino, Corso Dogliotti 14, I 10121 Torino, Italy
    Diabetes Care 31:940-4. 2008
  3. ncbi Role of the decreased nitric oxide bioavailability in the vascular complications of diabetes mellitus
    Andi Masha
    Department of Internal Medicine, Division of Endocrinology, Diabetology and Metabolism, University of Torino, C so A M Dogliotti 14, 10126, Torino, Italy
    Curr Pharm Biotechnol 12:1354-63. 2011
  4. ncbi Transdermal oestradiol replacement therapy enhances platelet constitutive nitric oxide synthase activity in postmenopausal women with type 2 diabetes mellitus
    Valentino Martina
    Department of Internal Medicine, University of Turin, Italy
    Clin Endocrinol (Oxf) 57:371-5. 2002
  5. ncbi Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans
    Fabio Broglio
    Division of Endocrinology, Department of Internal Medicine, Erasmus University of Rotterdam, The Netherlands
    Clin Endocrinol (Oxf) 61:503-9. 2004
  6. ncbi Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences
    Andrea Benso
    Department of Clinical and Biological Sciences, University of Turin and San Luigi Hospital, Orbassano, Turin, Italy
    Semin Vasc Med 4:107-14. 2004

Collaborators

Detail Information

Publications6

  1. ncbi Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects
    Valentino Martina
    Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Italy
    Clin Endocrinol (Oxf) 64:260-4. 2006
    ..However, the mechanisms underlying this action are still unknown. It has recently been suggested that DHEA-S could delay atheroma formation through an increase in nitric oxide (NO) production...
  2. doi Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes
    Valentino Martina
    Department of Internal Medicine, University of Torino, Corso Dogliotti 14, I 10121 Torino, Italy
    Diabetes Care 31:940-4. 2008
    ..For this reason, we tested the effects of l-arginine (ARG) and N-acetylcysteine (NAC) administration in increasing NO bioavailability by reducing free radical formation...
  3. ncbi Role of the decreased nitric oxide bioavailability in the vascular complications of diabetes mellitus
    Andi Masha
    Department of Internal Medicine, Division of Endocrinology, Diabetology and Metabolism, University of Torino, C so A M Dogliotti 14, 10126, Torino, Italy
    Curr Pharm Biotechnol 12:1354-63. 2011
    ..Therefore the treatments proposed are based on the possibility to counteract the oxidation and, in this context, the physiopathological mechanisms strongly support the treatment with thiols...
  4. ncbi Transdermal oestradiol replacement therapy enhances platelet constitutive nitric oxide synthase activity in postmenopausal women with type 2 diabetes mellitus
    Valentino Martina
    Department of Internal Medicine, University of Turin, Italy
    Clin Endocrinol (Oxf) 57:371-5. 2002
    ..To determine whether treatment with transdermal oestrogen replacement therapy (TERT) in postmenopausal women with type 2 diabetes mellitus was able to increase the activity of constitutive nitric oxide synthase (cNOS) in platelets...
  5. ncbi Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans
    Fabio Broglio
    Division of Endocrinology, Department of Internal Medicine, Erasmus University of Rotterdam, The Netherlands
    Clin Endocrinol (Oxf) 61:503-9. 2004
    ..Whether hyperglycaemia and insulin directly inhibit ghrelin secretion still remains matter of debate. The aim of the present study was therefore to investigate further the regulatory effects of glucose and insulin on ghrelin secretion...
  6. ncbi Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences
    Andrea Benso
    Department of Clinical and Biological Sciences, University of Turin and San Luigi Hospital, Orbassano, Turin, Italy
    Semin Vasc Med 4:107-14. 2004
    ..These actions indicate their potential pharmacotherapeutic implications in cardiovascular diseases...